Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedNew page revision v3.5.4 has been published, replacing the previous v3.5.3. This represents a minor update to the page's version tag and metadata, with no changes to study content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe version/revision tag for the ClinicalTrials.gov page display was updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the underlying study record.SummaryDifference0.0%

- Check41 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Naples, Campania, Italy, 80131 and removed Napoli, Campania, Italy, 80131 in the Locations list to standardize the site name to English.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated to v3.5.0; v3.4.3 removed.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.